美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

减肥药

1,174.27

+0.09550.01%

涨家数：2

跌家数：5

平家数：- -

市盈率：- -

高：1,179.07

开：1,172.78

低：1,167.09

收：1,174.17

成交量：5,691.45万

成交额：38.85亿

市值：1.25万亿

流通市值：1.18万亿

数据加载中...

医药行业创新药周报：2025年8月第四周创新药周报

诺和诺德欧股涨超3%

诺和诺德扳回一局称减重版司美格鲁肽心血管获益优于替尔泊肽

在GLP-1（胰高血糖素样肽-1）减肥药的竞争中诺和诺德的司美格鲁肽终于凭借心血管方面的获益扳回一局。9月1日记者从诺和

礼来Muvalaplin片启动III期临床适应症为降低伴Lp(a)水平升高患者MACE发生风险

诺和诺德加码开发srRNA新药治疗肥胖和糖尿病

复星医药引进TYK2/JAK1抑制剂；勃林格殷格翰口服HER2抑制剂在华获批上市

Ofweek光电信息网

诺和诺德(NVO.US)Wegovy心血管获益显著较礼来(LLY.US)Zepbound风险降幅达57%

诺和诺德5.5亿美元引进代谢药；迈威生物重递港股申请

21世纪经济报道

长效生长激素“元年”启幕，从“日剂”到“周剂”百亿市场竞争格局生变

速递｜5.5亿美元合作达成！诺和诺德剑指srRNA新减肥药

GLP1减重宝典

美国 FDA 批准卫材-百健的阿尔茨海默氏症药物注射剂上市

诺和诺德新CEO上任三把火，5.5亿美元押注RNA技术

MedTrend医趋势

诺和诺德困境促使丹麦下调2025年经济增长预期

礼来与京东健康达成战略合作

丹麦将2025年经济增长预测下调逾一半因诺和诺德前景疲软。

礼来向药房提供机密文件制定方案可节省最大剂量药物成本83英镑

减肥药物Mounjaro在英国药房将提供折扣，价格上调同时生效

美国FDA批准梯瓦制药的肥胖症仿制药

FDA批准了更新的莫德纳和辉瑞新冠疫苗用于秋冬病毒季节FDA Approves Updated Moderna and Pfizer COVID-19 Vaccines for Fall and Winter Virus Season

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4599/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"减肥药","latestPrice":1174.2664,"timestamp":1756929599999,"preClose":1174.1709,"halted":0,"volume":56914534,"delay":0,"changeRate":0.000081,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0.095459,"latestTime":"09-03 16:00:00 EDT","open":1172.7805,"high":1179.0726,"low":1167.092,"amount":3884895841.789631,"amplitude":0.010203,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1756944000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.474848,"peRate":25.093128,"turnoverRate":0.005379,"increases":2,"decrements":5,"flats":0,"marketCap":1248431845408,"floatMarketCap":1175388220640},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1179.0726,"amplitude":0.010203,"preClose":1174.1709,"low":1167.092,"pbRate":"8.474848","latestPrice":1174.2664,"volume":56914534,"delay":0,"open":1172.7805,"prevYearClose":1305.0607,"prevWeekClose":1170.4948,"prevMonthClose":1170.4948,"prevQuarterClose":1245.5326,"fiveDayClose":1171.8711,"twentyDayClose":1172.0867,"sixtyDayClose":1257.8302,"secType":"PLATE","market":"US","turnoverRate":0.005379,"peRate":25.093128,"marketCap":1248431845408,"floatMarketCap":1175388220640,"timestamp":1756929599999,"nameCN":"减肥药"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":2,"down":5,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2564897615","title":"医药行业创新药周报：2025年8月第四周创新药周报","url":"https://stock-news.laohu8.com/highlight/detail?id=2564897615","media":"西南证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564897615?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 16:11","pubTimestamp":1756714314,"startTime":"0","endTime":"0","summary":"A股和港股创新药板块及XBI指数本周走势2025年8月第四周，陆港两地创新药板块共计27个股上涨，81个股下跌。近6个月港股创新药累计上涨135.27%，跑赢恒生指数125.96pp，恒生医疗保健累计上涨59.02%。8月日本2款创新药获批上市，本周日本无创新药获批上市。本周全球重点创新药交易进展本周全球共达成9起重点交易，披露金额的重点交易有7起。GilgameshPharmaceuticals与AbbVie签订协议，交易金额为12亿美金。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901161352950b99d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901161352950b99d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","NVO","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756168.USD","LU1093756325.SGD","O","BK4585","BK4532","LU0154236417.USD","BK4588"],"gpt_icon":1},{"id":"2564917888","title":"诺和诺德欧股涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564917888","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564917888?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 15:08","pubTimestamp":1756710521,"startTime":"0","endTime":"0","summary":"格隆汇9月1日｜诺和诺德股价上涨超3%，此前在一项针对心脏病的现实研究中，诺和诺德的Wegovy击败了礼来的Zepbound。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901150913976fd688&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901150913976fd688&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4532","LU1093756168.USD","BK4599","BK4585","IE00BKVL7J92.USD","LU0154236417.USD","BK4007","NVO"],"gpt_icon":0},{"id":"2564995908","title":"诺和诺德扳回一局 称减重版司美格鲁肽心血管获益优于替尔泊肽","url":"https://stock-news.laohu8.com/highlight/detail?id=2564995908","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564995908?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 14:35","pubTimestamp":1756708500,"startTime":"0","endTime":"0","summary":"诺和诺德相关负责人指出，这一数据证实了司美格鲁肽的独特性，它是目前唯一一款在肥胖且伴有心血管疾病但无糖尿病的患者中，被证实具有心血管获益的GLP-1类药物。替尔泊肽组平均减重22.8kg，司美格鲁肽组平均减重15kg。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901143704a708b5b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901143704a708b5b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","IE00BZ1G4Q59.USD","BK4599","LU1093756325.SGD","BK4585","LU1093756168.USD","NVO","BK4007","BK4532","IE00BKVL7J92.USD","BK4588"],"gpt_icon":1},{"id":"2564807899","title":"在GLP-1（胰高血糖素样肽-1）减肥药的竞争中诺和诺德的司美格鲁肽终于凭借心血管方面的获益扳回一局。9月1日记者从诺和","url":"https://stock-news.laohu8.com/highlight/detail?id=2564807899","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564807899?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 14:33","pubTimestamp":1756708413,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4157","LU0154236417.USD","NVO","IE00BZ1G4Q59.USD","LU1093756168.USD","LU1093756325.SGD","BK4599","MACE","BK4590","BK4183","BK4588","IE00BKVL7J92.USD","BK4007","BK4144","BK4532","GLP","BK4585"],"gpt_icon":0},{"id":"2564898466","title":"礼来Muvalaplin片启动III期临床 适应症为降低伴Lp(a)水平升高患者MACE发生风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2564898466","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564898466?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 12:31","pubTimestamp":1756701060,"startTime":"0","endTime":"0","summary":"本次试验主要目的为在伴有Lp水平升高且发生过ASCVD事件或发生首次ASCVD事件风险升高的成人参与者中评价Muvalaplin对主要不良心血管事件影响。Muvalaplin片为化学药物，适应症为在伴Lp水平升高且已确诊CVD或发生首次CVE风险升高的患者中，降低MACE的发生风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901123802976f95b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901123802976f95b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0094547139.USD","LU1267930730.SGD","LU2468319806.SGD","LU0432979614.USD","LU0672654240.SGD","LU1061106388.HKD","SGXZ57979304.SGD","LU0385154629.USD","LU0114720955.EUR","SGXZ51526630.SGD","LU0198837287.USD","LU2746668461.USD","LU0097036916.USD","LU0122379950.USD","LU0466842654.USD","LU1548497426.USD","LU0109391861.USD","LU0203201768.USD","LU0823434583.USD","SG9999018865.SGD","LU2237443622.USD","SGXZ99366536.SGD","BK4599","SGXZ81514606.USD","LLY","LU0256863902.USD","LU1720051017.SGD","LU0354030511.USD","LU0471298777.SGD","LU0079474960.USD","SG9999018857.SGD","III","LU2461242641.AUD","LU2471134952.CNY","LU2552382215.SGD","GB00BDT5M118.USD","LU0238689110.USD","LU0889565916.HKD","LU2237438978.USD","LU2237443549.SGD","LU2602419157.SGD","LU2750360997.AUD","LU2746668974.SGD","LU1280957306.USD","BK4588","LU1974910355.USD","LU1366192091.USD","LU2491050071.SGD","Y","IE00B2B36J28.USD","MACE"],"gpt_icon":1},{"id":"2564645958","title":"诺和诺德加码开发srRNA新药治疗肥胖和糖尿病","url":"https://stock-news.laohu8.com/highlight/detail?id=2564645958","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564645958?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 09:58","pubTimestamp":1756691880,"startTime":"0","endTime":"0","summary":"诺和诺德与Replicate Bioscience签署5.5亿美元合作协议，共同开发srRNA新药，旨在治疗肥胖、2型糖尿病等心脏代谢疾病，利用srRNA技术提高蛋白质表达，为更多患者提供新治疗机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901101757950af9b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901101757950af9b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4588","BK4599","BK4585","LU1093756168.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4532","IE00BKVL7J92.USD","NVO","LU0154236417.USD","O"],"gpt_icon":0},{"id":"2564864543","title":"复星医药引进TYK2/JAK1抑制剂；勃林格殷格翰口服HER2抑制剂在华获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2564864543","media":"Ofweek光电信息网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564864543?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 09:34","pubTimestamp":1756690440,"startTime":"0","endTime":"0","summary":"口服HER2抑制剂在华获批上市。2）勃林格殷格翰口服HER2抑制剂在华获批上市8月29日，据NMPA官网，勃林格殷格翰的宗艾替尼片的上市申请已获批准，用于治疗存在HER2激活突变且既往接受过至少一种系统治疗的不可切除的局部晚期或转移性非小细胞肺癌成人患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901094845950aea4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901094845950aea4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","LU0154236417.USD","IE00BKVL7J92.USD","02196","BK4007","BK4585","LU1093756168.USD","BK4588","O","NVO","BK4532","01276","BK4599","LU1093756325.SGD"],"gpt_icon":1},{"id":"2564866448","title":"诺和诺德(NVO.US)Wegovy心血管获益显著 较礼来(LLY.US)Zepbound风险降幅达57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564866448","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564866448?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 08:50","pubTimestamp":1756687840,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SGXZ57979304.SGD","LU0006306889.USD","LU1983299246.USD","IE00BZ1G4Q59.USD","BK4599","LU2456880835.USD","LU1057294990.SGD","LU0097036916.USD","LU0417517546.SGD","LU2063271972.USD","LU2264538146.SGD","LU2357305700.SGD","LU2106854487.HKD","LU2491050154.USD","LU0154236417.USD","NVO","LU2750360641.GBP","BK4585","LU2552382132.HKD","LU1988902786.USD","LU2237443978.SGD","LU0122379950.USD","LU1868836757.USD","LU2471134796.USD","SG9999014898.SGD","LU0640476718.USD","LU2491049909.HKD","LU0234572021.USD","SG9999018857.SGD","LU2491050071.SGD","SG9999001176.USD","LU0708995401.HKD","SG9999015986.USD","LU2361045086.USD","IE00B4R5TH58.HKD","LU0316494557.USD","BK4532","LU2023250504.SGD","LU2211815571.USD","LU1069344957.HKD","LLY","LU0354030511.USD","LU0786609619.USD","SGXZ99366536.SGD","LU1093756325.SGD","LU2552382058.USD","LU1093756168.USD","LU1023059063.AUD","LU2237443622.USD","LU0823416689.USD"],"gpt_icon":0},{"id":"2564865883","title":"诺和诺德5.5亿美元引进代谢药；迈威生物重递港股申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2564865883","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564865883?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 08:08","pubTimestamp":1756685287,"startTime":"0","endTime":"0","summary":"政策动向广州“穗新保”新增60种创新药械和6家医院8月28日，广州市医保局举办“穗新保”新增试点医院签约活动，6家试点商保公司与6家新增试点医疗机构签署合作协议。广州快速推进“穗新保”扩容提质，全新升级“穗新保”保障范围，新增“60+6”的产品目录及试点医院。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509013500397873.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509013500397873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","BK4588","IE00BZ1G4Q59.USD","LU1093756325.SGD","LU0154236417.USD","IE00BKVL7J92.USD","YANG","BK4599","LU1093756168.USD","NVO","BK4532","BK4614","BK4007","HSCEI","HSTECH"],"gpt_icon":1},{"id":"2564866024","title":"长效生长激素“元年”启幕，从“日剂”到“周剂”百亿市场竞争格局生变","url":"https://stock-news.laohu8.com/highlight/detail?id=2564866024","media":"动脉网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564866024?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 08:02","pubTimestamp":1756684948,"startTime":"0","endTime":"0","summary":"国内长效生长激素市场正逐渐从单一参与者变为维升药业、特宝生物、金赛药业、安科生物、诺和诺德等多方竞争的格局。弗若斯特沙利文数据显示，预计国内长效生长激素市场规模将在两年内超过短效生长激素，并在2030年占据生长激素全市场73.8%。相比于国内GLP-1长效制剂百条管线激烈角逐的盛况，长效生长激素的竞争相对缓和。据梳理，过往在长效生长激素研发过程中“摔跟头”的企业不在少数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901080521a4abf309&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901080521a4abf309&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE00BMG7P819.SGD","IE00BMG7P926.USD","IE00BKVL7J92.USD","PEG","LU1093756168.USD","LU1093756325.SGD","BK4532","IE00BD4GTT62.SGD","IE00BZ1G4Q59.USD","O","BK4599","NVO","IE00BD4GTW91.USD","BK4208","02561","LU0154236417.USD","IE00BD4GTV84.USD","IE00BMG7P587.USD","LU2346227817.USD","IE00BMG7P694.USD","BK4585","BK4588"],"gpt_icon":1},{"id":"2563883446","title":"速递｜5.5亿美元合作达成！诺和诺德剑指srRNA新减肥药","url":"https://stock-news.laohu8.com/highlight/detail?id=2563883446","media":"GLP1减重宝典","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563883446?lang=zh_cn&edition=fundamental","pubTime":"2025-08-30 18:21","pubTimestamp":1756549297,"startTime":"0","endTime":"0","summary":"合作的重点是结合诺和诺德在心脏代谢领域的研发与临床优势，与Replicate独特的srRNA平台共同开发创新候选药物，用于肥胖、2型糖尿病及相关慢性病。诺和诺德将获得独家全球权利，使用Replicate的srRNA平台进行项目推进和商业化。目前，Replicate正在推进的重点项目包括针对IL-1受体激动剂和IL-18结合蛋白的srRNA药物，旨在双重阻断炎症小体激活后的细胞因子信号通路，这一机制与慢性炎症性肠病、痛风以及复发性心包炎等疾病密切相关。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250830184139a705bd32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250830184139a705bd32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4007","IE00BKVL7J92.USD","LU0154236417.USD","BK4532","BK4588","IE00BZ1G4Q59.USD","LU1093756325.SGD","O","BK4599","NVO","LU1093756168.USD"],"gpt_icon":0},{"id":"2563725730","title":"美国 FDA 批准卫材-百健的阿尔茨海默氏症药物注射剂上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2563725730","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563725730?lang=zh_cn&edition=fundamental","pubTime":"2025-08-30 05:00","pubTimestamp":1756501239,"startTime":"0","endTime":"0","summary":"路透8月29日 - 美国食品和药物管理局已批准了卫材4523.T和百健BIIB.O的阿尔茨海默病药物Leqembi的注射剂，这两家公司周五表示，在最初的静脉输液之后，可以选择更简便的治疗方法。这项批准使Leqembi成为第一种可以每周在家皮下注射的阿尔茨海默氏症治疗药物，减少了患者现在需要每月两次前往输液中心进行大约一小时输液的麻烦。两家公司称，Leqembi IQLIK将于10月6日向患者上市，360毫克单剂量预充式自动注射器的年上市价格为19,500美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nL4T3UL1F0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","IE00B4R5TH58.HKD","LU2491049909.HKD","LU2461242641.AUD","LU0266013472.USD","LU2357305700.SGD","LU1868836757.USD","LU2471134796.USD","LU2750360997.AUD","IE00B19Z9Z06.USD","SG9999018857.SGD","IE0002141913.USD","LU2237443549.SGD","LU1720051017.SGD","LU0234572021.USD","BK4599","BIIB","SG9999014898.SGD","LU2237443382.USD","LU2746668974.SGD","BK4588","LU1267930730.SGD","LU0320765059.SGD","BK4139","LU1804176565.USD","LU1280957306.USD","LU1093756168.USD","IE00BK4W5L77.USD","LU1064131342.USD","LU1127390331.HKD","SG9999014914.USD","LU0471298777.SGD","LU2462157665.USD","IE00B1BXHZ80.USD","LU0122379950.USD","LU2237443895.HKD","SG9999015986.USD","LU1988902786.USD","LU2361044949.HKD","LU0238689110.USD","LU1551013425.SGD","SG9999013999.USD","SG9999015978.USD","LU1057294990.SGD","LU1548497426.USD","BK4516","SG9999014906.USD","LU0943347566.SGD","IE00BJT1NW94.SGD"],"gpt_icon":1},{"id":"2563408028","title":"诺和诺德新CEO上任三把火，5.5亿美元押注RNA技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2563408028","media":"MedTrend医趋势","labels":["executive","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563408028?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 18:25","pubTimestamp":1756463138,"startTime":"0","endTime":"0","summary":"8月28日，其上任后的首次并购交易成功落地，聚焦于新型RNA技术领域。作为肥胖症治疗领域的先行者，诺和诺德在下一代药物的研发竞赛中逐渐面临挑战，如今该公司正寄望于新型RNA技术，以强化其早期研发管线。诺和诺德已与Replicate生物科学公司签署了一项为期多年的研究合作协议，协议潜在总价值高达5.5亿美元。根据该声明，Replicate将获得一笔预付款，若后续达到相关里程碑节点，还可获得额外款项，协议总价值最高可达5.5亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829194940a4a7b5c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829194940a4a7b5c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","BK4585","BK4588","BK4139","BK4505","IE00BKVL7J92.USD","LU0154236417.USD","O","RNA","BK4599","BK4532","LU1093756325.SGD","LU1093756168.USD","BK4007","IE00BZ1G4Q59.USD"],"gpt_icon":1},{"id":"2563017309","title":"诺和诺德困境促使丹麦下调2025年经济增长预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2563017309","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563017309?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 16:31","pubTimestamp":1756456314,"startTime":"0","endTime":"0","summary":"更新版 1-更新 1-诺和诺德困境促使丹麦下调2025年经济增长预期在第 2 段中增加了部委引文，在第 4 和第 5 段中增加了背景和环境，在第 6 段中增加了出口，在第 9 段中增加了 2026 年国内生产总值预测，改变了来源。路透8月29日 - 丹麦经济部周五表示，丹麦已将2025年的经济增长预期从3%下调至1.4%，理由是制药巨头  诺和诺德NOVOb.CO的前景较弱，以及丹麦出口美国的商品被征收关税。诺和诺德公司发言人拒绝发表评论。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nL4T3UL0J4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BK4W5L77.USD","LU0256863811.USD","LU0823416689.USD","LU2237438978.USD","LU0471298694.HKD","LU2456880835.USD","LU2746668461.USD","IE0002141913.USD","LU0820561818.USD","BK4533","SG9999015945.SGD","LU1868836591.USD","BK4588","LU0320765992.SGD","LU0466842654.USD","IE00BFTCPJ56.SGD","LU0708995401.HKD","LU0786609619.USD","LU1023059063.AUD","LU0109394709.USD","IE00BK4W5M84.HKD","IE00BJLML261.HKD","GB00BDT5M118.USD","LU1989771016.USD","LU0385154629.USD","LU0109391861.USD","LU1064131342.USD","LU0354030438.USD","LU1267930730.SGD","LU0122379950.USD","IE00B4R5TH58.HKD","LU0823434740.USD","LU0889565916.HKD","SG9999001176.USD","SG9999014914.USD","LU2265009873.SGD","LU0823434583.USD","IE0004445239.USD","LU1061106388.HKD","LU1868837300.USD","BK4599","LU0323591593.USD","IE00BJJMRZ35.SGD","LU2360106947.USD","LU1868837136.USD","LU2108987350.USD","LU1366192091.USD","SG9999001176.SGD","LU2237443978.SGD"],"gpt_icon":1},{"id":"2563090488","title":"礼来与京东健康达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2563090488","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563090488?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 12:35","pubTimestamp":1756442127,"startTime":"0","endTime":"0","summary":"人民财讯8月29日电，8月29日，礼来中国宣布与京东健康达成战略合作伙伴，旨在为超重/肥胖、2型糖尿病和斑秃人群打造创新的数字医疗体验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829123527a703086a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250829123527a703086a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999001176.SGD","SG9999015945.SGD","LU1868836591.USD","LU0354030511.USD","SG9999018857.SGD","SG9999014914.USD","LU2361044865.SGD","SG9999015978.USD","BK4007","SG9999014898.SGD","SG9999017495.SGD","LU0823434583.USD","LU0320765992.SGD","LU0006306889.USD","LU1280957306.USD","SG9999013999.USD","LU0079474960.USD","LU0203201768.USD","LU0471298694.HKD","LU0094547139.USD","LU2602419157.SGD","LU1061106388.HKD","LU0823434740.USD","LU2237443978.SGD","LU0289739699.SGD","LU1868837136.USD","LU1868836757.USD","IE00B2B36J28.USD","LU0385154629.USD","IE00BJT1NW94.SGD","LU2211815571.USD","LU1267930730.SGD","BK4581","LU1093756168.USD","LU2237438978.USD","BK4599","BK4585","LU0096364046.USD","LU0203202063.USD","LLY","LU0672654240.SGD","LU2265009873.SGD","LU2471134796.USD","LU1804176565.USD","Y","GB00BDT5M118.USD","LU0820561909.HKD","LU1868836914.USD","IE0004445239.USD","LU2491050071.SGD"],"gpt_icon":0},{"id":"2563065335","title":"丹麦将2025年经济增长预测下调逾一半因诺和诺德前景疲软。","url":"https://stock-news.laohu8.com/highlight/detail?id=2563065335","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563065335?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 03:33","pubTimestamp":1756409606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BKVL7J92.USD","BK4599","NVO","BK4588","LU1093756168.USD","BK4532","IE00BZ1G4Q59.USD","BK4585","LU0154236417.USD","LU1093756325.SGD","BK4007"],"gpt_icon":0},{"id":"1155498895","title":"礼来向药房提供机密文件 制定方案可节省最大剂量药物成本83英镑","url":"https://stock-news.laohu8.com/highlight/detail?id=1155498895","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155498895?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 23:44","pubTimestamp":1756395879,"startTime":"0","endTime":"0","summary":"据机密文件显示，制药商礼来已向药房提供一项方案，该方案能够在最大剂量药物成本上实现83英镑的节省。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","LU1551013342.USD","LU2750360997.AUD","BK4007","SGXZ99366536.SGD","LU0820561818.USD","LU0320765992.SGD","LU0432979614.USD","LU2602419157.SGD","IE00BK4W5M84.HKD","LU2237443978.SGD","LU0289739699.SGD","LU0266013472.USD","LU1868837136.USD","LU0708995401.HKD","LU0689472784.USD","LU1267930730.SGD","LU1623119135.USD","LU1366192091.USD","LU2089984988.USD","LU2063271972.USD","LU2456880835.USD","LU0640476718.USD","LLY","LU1720051017.SGD","LU0466842654.USD","LU1804176565.USD","LU1814569148.SGD","LU2471134952.CNY","LU0456855351.SGD","LU2106854487.HKD","LU2746668461.USD","LU1868836914.USD","LU2491050154.USD","IE0004445239.USD","LU1548497426.USD","LU1989771016.USD","LU2237443382.USD","LU2237443465.HKD","IE00B4R5TH58.HKD","LU1868836591.USD","LU1093756325.SGD","LU0354030511.USD","SG9999018857.SGD","LU2491049909.HKD","LU0882574055.USD","LU2361044865.SGD","SG9999015978.USD","SG9999014898.SGD","LU1035775433.USD","LU0823434583.USD","LU2552382058.USD","LU0079474960.USD","LU0114720955.EUR","LU2417539215.USD","LU0256863811.USD","LU1093756168.USD","LU0323591593.USD","LU2324357040.USD","LU1057294990.SGD","LU2265009873.SGD","BK4588","LU1551013425.SGD","SGXZ57979304.SGD","BK4533","LU2552382215.SGD","LU2108987350.USD","LU2471134879.HKD","LU1712237335.SGD","LU1988902786.USD","LU2361045086.USD","LU2491050071.SGD","LU0058720904.USD","BK4516","SG9999001176.SGD","LU0316494557.USD","IE00BJLML261.HKD","SG9999014914.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","SG9999017495.SGD","SG9999014906.USD","LU2361044949.HKD","LU1023059063.AUD","BK4534","LU1280957306.USD","SG9999013999.USD","LU0094547139.USD","LU0106261372.USD","LU1061106388.HKD","SGXZ81514606.USD","LU0417517546.SGD","LU2237443549.SGD","LU0385154629.USD","LU2462157665.USD","SGXZ31699556.SGD","LU0198837287.USD","LU0109391861.USD","LU2236285917.USD","LU2237438978.USD","SG9999015986.USD","BK4599","LU0097036916.USD","LU0096364046.USD","IE0002141913.USD","LU0234572021.USD","LU1917777945.USD","LU1720051108.HKD","IE00B1BXHZ80.USD","LU2471134796.USD","LU2461242641.AUD","GB00BDT5M118.USD","LU0122379950.USD","LU0820561909.HKD","LU0320765059.SGD","LU2237443895.HKD","SG9999015952.SGD","SG9999015945.SGD","LU1291159041.SGD","LU0006306889.USD","LU2360106947.USD","LU0203201768.USD","LU0471298694.HKD","SG9999001176.USD","IE0009355771.USD","LU0823434740.USD","LU2750360641.GBP","IE00BK4W5L77.USD","LU0889565916.HKD","LU0823416689.USD","LU1064131342.USD","LU0354030438.USD","LU2264538146.SGD","LU1868836757.USD","IE00B2B36J28.USD","LU2211815571.USD","IE00BJT1NW94.SGD","LU0882574139.USD","LU1127390331.HKD","LU2112291526.USD","LU1868837300.USD","LU2357305700.SGD","LU1069344957.HKD","BK4581","LU2552382132.HKD","SGXZ51526630.SGD","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU2237443622.USD","BK4585","LU0203202063.USD","LU0672654240.SGD","SG9999018865.SGD","LU0471298777.SGD","LU1232071149.USD","LU0943347566.SGD","LU2471134523.USD","LU0256863902.USD","LU0061475181.USD","LU0238689110.USD","LU0109394709.USD","LU2746668974.SGD","SG9999014880.SGD","LU1974910355.USD","LU0786609619.USD"],"gpt_icon":0},{"id":"1156622789","title":"减肥药物Mounjaro在英国药房将提供折扣，价格上调同时生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1156622789","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156622789?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 23:43","pubTimestamp":1756395809,"startTime":"0","endTime":"0","summary":"减肥药物Mounjaro在英国药房将提供折扣，价格上调同时生效","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361044949.HKD","LU2746668974.SGD","SG9999014906.USD","SGXZ81514606.USD","LU1057294990.SGD","LU2471134952.CNY","LU0385154629.USD","SG9999018865.SGD","LU1720051108.HKD","LU1804176565.USD","LU1548497426.USD","LU2211815571.USD","LU2265009873.SGD","BK4516","LU0471298694.HKD","LU0354030511.USD","LU0266013472.USD","LU2063271972.USD","IE00BJLML261.HKD","LU1291159041.SGD","LU0316494557.USD","LU1061106388.HKD","LU2552382132.HKD","LU1868836757.USD","LU2471134796.USD","LU0708995401.HKD","LU2746668461.USD","LU1712237335.SGD","LU0203201768.USD","LU2750360997.AUD","LU0122379950.USD","LU1868836914.USD","SG9999015978.USD","BK4533","LU0786609619.USD","LU0198837287.USD","SG9999013999.USD","BK4588","LU1064131342.USD","LU2324357040.USD","LU2491049909.HKD","LU2552382215.SGD","SG9999001176.SGD","SGXZ57979304.SGD","LU0882574139.USD","LU2750360641.GBP","LU1868837300.USD","LU2237443895.HKD","LU1623119135.USD","IE0009355771.USD","LU1023059063.AUD","LU0432979614.USD","LU0456855351.SGD","LU1232071149.USD","SG9999015952.SGD","IE00BK4W5M84.HKD","LU0256863902.USD","BK4007","LU0889565916.HKD","LU1093756325.SGD","IE00B4R5TH58.HKD","LU2471134523.USD","LU2023250504.SGD","LU2462157665.USD","LU2491050154.USD","LU0823416689.USD","GB00BDT5M118.USD","SG9999014898.SGD","LU1988902786.USD","LU0106261372.USD","LU2237443549.SGD","LU1814569148.SGD","IE00B1BXHZ80.USD","SG9999014880.SGD","LU2112291526.USD","LU1720051017.SGD","LU0079474960.USD","LU0094547139.USD","BK4534","LU2468319806.SGD","LU0471298777.SGD","LU1366192091.USD","SG9999018857.SGD","LU2237443978.SGD","IE00B2B36J28.USD","LU2552382058.USD","LU2602419157.SGD","LU0203202063.USD","LU0640476718.USD","LU0689472784.USD","LU0943347566.SGD","LU2236285917.USD","LU0238689110.USD","LU0109391861.USD","LU2237443622.USD","LU0323591593.USD","LU0256863811.USD","LU2237443465.HKD","IE00BFTCPJ56.SGD","LU2089984988.USD","LU0820561909.HKD","IE00BK4W5L77.USD","LU0114720955.EUR","LU1267930730.SGD","BK4585","LU1280957306.USD","LU1551013342.USD","LU2461242641.AUD","SGXZ51526630.SGD","SGXZ99366536.SGD","LU2108987350.USD","IE0002141913.USD","LU2264538146.SGD","LU0109394709.USD","LU2106854487.HKD","LU0823434583.USD","LU2471134879.HKD","IE00BJJMRZ35.SGD","LU1127390331.HKD","LU2361045086.USD","LU0097036916.USD","LU0061475181.USD","LU0058720904.USD","LU0320765059.SGD","LU1917777945.USD","LU1868836591.USD","SG9999001176.USD","LU0234572021.USD","LU0096364046.USD","LU0882574055.USD","LU2456880835.USD","SG9999017495.SGD","LU2491050071.SGD","LU2237438978.USD","LU2361044865.SGD","LU2237443382.USD","LU1093756168.USD","LLY","LU1069344957.HKD","LU0820561818.USD","IE00BJT1NW94.SGD","LU1868837136.USD","BK4599","LU1974910355.USD","SGXZ31699556.SGD","LU1551013425.SGD","LU1035775433.USD","SG9999014914.USD","LU0417517546.SGD","LU0354030438.USD","LU1989771016.USD","LU0672654240.SGD","LU0823434740.USD","BK4581","LU0289739699.SGD","LU2417539215.USD","LU0006306889.USD","LU0466842654.USD","LU1983299246.USD","SG9999015945.SGD","IE0004445239.USD","LU2357305700.SGD","LU0320765992.SGD","LU2360106947.USD","SG9999015986.USD"],"gpt_icon":0},{"id":"2562403716","title":"美国FDA批准梯瓦制药的肥胖症仿制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2562403716","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562403716?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 20:58","pubTimestamp":1756385890,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4566","LU0154236417.USD","BK4007","BK4559","BK4557","BK4596","NVO","IE00BKVL7J92.USD","BK4585","LU1093756325.SGD","BK4599","IE00BZ1G4Q59.USD","BK4532","LU1093756168.USD","TEVA","BK4588","BK4584"],"gpt_icon":0},{"id":"2563013649","title":"FDA批准了更新的莫德纳和辉瑞新冠疫苗用于秋冬病毒季节FDA Approves Updated Moderna and Pfizer COVID-19 Vaccines for Fall and Winter Virus Season","url":"https://stock-news.laohu8.com/highlight/detail?id=2563013649","media":"动脉网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563013649?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 20:06","pubTimestamp":1756382760,"startTime":"0","endTime":"0","summary":"The decision comes as health officials prepare for potential surges in COVID-19 cases during the fall and winter months. Moderna and Pfizer/BioNTech submitted updates to their vaccine formulas aimed at improving efficacy against newer strains circulating globally. The FDA’s authorization follows a review process that evaluated safety, effectiveness, and adaptability of the updated vaccines to current public health needs..该决定是在卫生官员为秋冬季节可能出现的新冠病例激增做准备之际作出的。莫德纳和辉瑞/生物新技术公司提交了针对其疫苗配方的更新，旨在提高对全球流行的新型毒株的有效性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508282009339502e491&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508282009339502e491&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4452.SGD","BK4550","BK4585","BK4533","BK4548","BK4568","BK4535","BK4599","LU0868494617.USD","LU1894683348.USD","SG9999003800.SGD","LU0306807586.USD","SG9999002224.SGD","IE00B19Z3B42.SGD","LU0225284248.USD","LU0321505868.SGD","SGXZ57979304.SGD","IE000M9KFDE8.USD","IE00B19Z3581.USD","BK4581","LU0225771236.USD","LU0289739699.SGD","LU1023059063.AUD","LU0122379950.USD","BK4534","BK4201","BNTX","BK4139","BK4551","IE00BLSP4239.USD","LU0234572021.USD","LU1066051498.USD","SG9999013999.USD","BK4588","LU0306806265.USD","LU1066053197.SGD","SG9999011175.SGD","LU0321505439.SGD","LU1883839398.USD","IE00BBT3K403.USD","LU0456855351.SGD","LU0985481810.HKD","IE0002270589.USD","LU1057294990.SGD","BK4007","BK4592","LU0058720904.USD","PFE","E","LU1894683264.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":104,"code":"91000000","status":"200"}]}}